WHAT SETS US APART
Study Startup
Contract / Budget Timelines
- Fast-track
- Reviewed within 1 week
Accelerated Start-Up Timeline
- Regulatory edits within 1 week
- SSU done during budget edits
Recruitment / Retention
- 14 clinics
- >20,000 patients per month
- Developed database
- In-house marketing
- Low s/f rate (<11%)
- Prescreening team
- Complimentary prescreening visits with a Sub-Investigator
- Spanish speaking staff
Community Engagement
- Pediatric providers
- RA
- Community events
- Informational dinners
- Podcast appearances
Quality Assurance
- Dedicated QA/Data entry staff
- 48-hour data entry/query resolution target
- Quarterly in-house mock audits
Experienced Site Staff
- CCRC
- GCP certified
- IATTA certified
- Members of SCRS, ACRP and SOCRA
Current Studies
Our portfolio includes a variety of marketed drugs such as Opzelura, Skyrizi, Otezla, Tremfya,as well as novel investigational drugs in various forms including topicals, oral medications, injectables, and IV therapies. We have conducted phase 1 through 4 trials for conditions such as psoriasis, eczema, hidradenitis suppurativa, vitiligo, lichen planus, alopecia, and more!